Skip to main content
Fig. 5 | European Journal of Medical Research

Fig. 5

From: siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy

Fig. 5

The effect of E6-siRNA and Oxaliplatin combination on stemness features. A. In the combination group, the number of colonies decreases significantly compared to control group. B, D. In the combination group, stem cell markers (CD133 and  CD44) had shown slight changes compared to the other groups. C. In the combination group, the expression level of the Nanog stemness gene showed significant changes compared to the other groups, and the number of colonies altered depending on the Nanog pathway (*p < 0.05, **p < 0.01, ****p < 0.0001)

Back to article page